SMIC Signs Cooperation Agreement to Invest in Wuhan Xinxin’s 12-Inch Wafer Production Facilities

The Wuhan East Lake Hi-Tech Development Zone Administrative Committee and Semiconductor Manufacturing International Corporation ("SMIC," NYSE: SMI, SEHK: 0981.HK) today signed a cooperation framework agreement in Wuhan's East Lake Hotel in which both parties agreed to cooperate and jointly invest in the 12-inch wafer production facilities of Wuhan Xinxin Semiconductor Manufacturing Corporation (Wuhan Xinxin) through cash injection.

The official signing ceremony was attended by the President of the Chinese Academy of Engineering Zhou Ji; officials from the National Development and Reform Commission, China Development Bank, and Hubei Province; Wuhan City Party Secretary Yang Song; Wuhan Mayor Ruan Chengfa; SMIC Chairman Jiang Shangzhou; SMIC President and C.E.O. David N.K. Wang; and others.

SMIC began its cooperation with Wuhan City in early 2006 when its government funded and constructed Wuhan Xinxin and engaged SMIC to manage it. Wuhan Xinxin commenced production in September 2008, with its fab construction and operations meeting global industry standards. The signing of this new agreement strengthens the commitment between SMIC's new management team and the Wuhan government to move towards greater expansion and development.

The cooperation framework agreement proposes a possible joint venture driven by corporate responsibility and profitability, which will focus on 65-40 nanometer integrated circuits with a goal of achieving a production capacity of 45,000 wafers per month within three years of its establishment. Capacity planning for this new phase will be consistent with industry standards for profitable development, with products and technology driven by market demand.

This cooperation will benefit both parties and serve as a strategic component in SMIC's expansion plan over the next five years. It also will become a key contributor to the Chinese and global semiconductor industries, as a reliable platform for high-end chip manufacturing.

Through this agreement, SMIC and Wuhan City will collaborate extensively in areas such as talent development, chip design, and supply chain improvement, to promote the economic development of Wuhan's "Optics Valley" and upgrade Hubei Province's information & technology industry. As East Lake High-tech Zone is developing its strategy to build the "National Innovation Model Area" and "China Optical Valley," this cooperation will become an innovation engine to drive their development.

Source: http://www.smics.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Semiconductor Manufacturing International Corporation (SMIC). (2019, February 13). SMIC Signs Cooperation Agreement to Invest in Wuhan Xinxin’s 12-Inch Wafer Production Facilities. AZoNano. Retrieved on April 18, 2024 from https://www.azonano.com/news.aspx?newsID=20251.

  • MLA

    Semiconductor Manufacturing International Corporation (SMIC). "SMIC Signs Cooperation Agreement to Invest in Wuhan Xinxin’s 12-Inch Wafer Production Facilities". AZoNano. 18 April 2024. <https://www.azonano.com/news.aspx?newsID=20251>.

  • Chicago

    Semiconductor Manufacturing International Corporation (SMIC). "SMIC Signs Cooperation Agreement to Invest in Wuhan Xinxin’s 12-Inch Wafer Production Facilities". AZoNano. https://www.azonano.com/news.aspx?newsID=20251. (accessed April 18, 2024).

  • Harvard

    Semiconductor Manufacturing International Corporation (SMIC). 2019. SMIC Signs Cooperation Agreement to Invest in Wuhan Xinxin’s 12-Inch Wafer Production Facilities. AZoNano, viewed 18 April 2024, https://www.azonano.com/news.aspx?newsID=20251.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.